HK1201761A1 - Functionalization of biomaterials to control regeneration and inflammation responses - Google Patents
Functionalization of biomaterials to control regeneration and inflammation responsesInfo
- Publication number
- HK1201761A1 HK1201761A1 HK15102410.1A HK15102410A HK1201761A1 HK 1201761 A1 HK1201761 A1 HK 1201761A1 HK 15102410 A HK15102410 A HK 15102410A HK 1201761 A1 HK1201761 A1 HK 1201761A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- biomaterials
- functionalization
- control regeneration
- inflammation responses
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161581364P | 2011-12-29 | 2011-12-29 | |
PCT/US2012/072275 WO2013102193A1 (fr) | 2011-12-29 | 2012-12-31 | Fonctionnalisation de biomatériaux pour commander la régénération et des réponses à une inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201761A1 true HK1201761A1 (en) | 2015-09-11 |
Family
ID=48698691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102410.1A HK1201761A1 (en) | 2011-12-29 | 2015-03-10 | Functionalization of biomaterials to control regeneration and inflammation responses |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150010630A1 (fr) |
EP (1) | EP2797641B1 (fr) |
KR (1) | KR20140108705A (fr) |
BR (1) | BR112014016154A8 (fr) |
CA (1) | CA2865796A1 (fr) |
HK (1) | HK1201761A1 (fr) |
WO (1) | WO2013102193A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201113856D0 (en) * | 2011-08-11 | 2011-09-28 | Oxford Biomaterials Ltd | Medical device |
WO2015027144A1 (fr) * | 2013-08-22 | 2015-02-26 | Allergan, Inc. | Dispositifs médicaux implantables |
US20160199450A1 (en) * | 2013-08-26 | 2016-07-14 | The Trustees Of Columbia University In The City Of New York | Scaffolds containing cytokines for tissue engineering |
WO2015054125A1 (fr) * | 2013-10-08 | 2015-04-16 | Trustees Of Tufts College | Hydrogels réticulés de manière covalente, à propriétés réglables et procédés pour les fabriquer |
US10098982B2 (en) | 2013-11-20 | 2018-10-16 | Drexel University | Compositions and methods for macrophage conversion |
WO2015081253A1 (fr) * | 2013-11-26 | 2015-06-04 | Biomet Biologics, Llc | Procédés de médiation des phénotypes macrophagiques |
GB201415681D0 (en) | 2014-09-04 | 2014-10-22 | Cambridge Entpr Ltd And President And Fellows Of Harvard College | Protien Capsules |
CN108431028B (zh) * | 2015-10-27 | 2023-09-26 | 珀杜研究基金会 | 用于诱导性脂肪褐变的基于聚合物的治疗剂 |
WO2018081805A1 (fr) | 2016-10-31 | 2018-05-03 | Sofregen Medical, Inc. | Compositions comprenant des fragments de fibroïne de soie à faible poids moléculaire et des plastifiants |
WO2018095264A1 (fr) * | 2016-11-22 | 2018-05-31 | 陈艳丽 | Ostéogenèse régulée par un régulateur de la voie de signalisation notch |
WO2018156613A1 (fr) * | 2017-02-21 | 2018-08-30 | Trustees Of Tufts College | Stent trachéal de fibroïne de soie |
US20210121606A1 (en) * | 2017-05-26 | 2021-04-29 | Association For The Advancement Of Tissue Engineering Cell Based Technologies & Theapies (A4Tec) | Ionic-doped composition methods and uses thereof |
WO2019094702A1 (fr) | 2017-11-10 | 2019-05-16 | Cocoon Biotech Inc. | Applications oculaires de produits à base de soie |
US11773533B2 (en) * | 2017-12-05 | 2023-10-03 | Università degli Studi di Roma “La Sapienza” | Composition for use in the finishing, preservation, restoration of manufactures |
EP3737415A4 (fr) * | 2018-01-12 | 2021-06-30 | President and Fellows of Harvard College | Compositions et méthodes associées à des macrophages et/ou à des monocytes à particules adhérentes |
EP4045124A4 (fr) | 2019-10-15 | 2024-01-24 | Sofregen Medical Inc | Dispositifs de distribution pour l'administration et procédés de distribution de compositions |
CN111888522B (zh) * | 2020-09-22 | 2022-12-20 | 中山大学附属口腔医院 | 一种具有免疫调控功能的牙周再生材料及其制备方法 |
CN112451732A (zh) * | 2020-11-27 | 2021-03-09 | 山东大学 | 一种单侧负载银的丝素蛋白抗菌敷料及制备方法和应用 |
CN115487350B (zh) * | 2021-06-17 | 2023-10-31 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种调节免疫炎症微环境水凝胶支架及其制备方法和应用 |
CN113813445A (zh) * | 2021-10-08 | 2021-12-21 | 苏州大学 | 一种丝素蛋白复合多孔支架及其制备方法 |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5612114B2 (fr) | 1974-06-07 | 1981-03-18 | ||
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
AU548996B2 (en) | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
AU570021B2 (en) | 1982-11-22 | 1988-03-03 | Novartis Ag | Analogs of mevalolactone |
US4681893A (en) | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
JP2569746B2 (ja) | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
US5753675A (en) | 1989-03-03 | 1998-05-19 | Novartis Pharmaceuticals Corporation | Quinoline analogs of mevalonolactone and derivatives thereof |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
US5245012A (en) | 1990-04-19 | 1993-09-14 | The United States Of America As Represented By The Secretary Of The Army | Method to achieve solubilization of spider silk proteins |
US5177080A (en) | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
JPH07501451A (ja) | 1991-11-25 | 1995-02-16 | エンゾン・インコーポレイテッド | 多価抗原結合タンパク質 |
WO1996013275A1 (fr) * | 1994-10-31 | 1996-05-09 | Tkb Associates Limited Partnership | Procedes et produits permettant d'ameliorer les reactions immunitaires |
CN1200145A (zh) | 1995-08-22 | 1998-11-25 | 阿格里科拉技术有限公司 | 高强度蛛丝蛋白的克隆方法 |
US6841543B1 (en) * | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
US6175053B1 (en) | 1997-06-18 | 2001-01-16 | Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forrestry And Fisheries | Wound dressing material containing silk fibroin and sericin as main component and method for preparing same |
US6287340B1 (en) | 1999-05-14 | 2001-09-11 | Trustees Of Tufts College | Bioengineered anterior cruciate ligament |
JP2001163899A (ja) | 1999-12-09 | 2001-06-19 | Natl Inst Of Sericultural & Entomological Science | 機能性絹フィブロインの製造方法とその利用 |
US6902932B2 (en) | 2001-11-16 | 2005-06-07 | Tissue Regeneration, Inc. | Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
US20110009960A1 (en) | 2001-11-16 | 2011-01-13 | Allergan, Inc. | Prosthetic fabric structure |
EP2662211A1 (fr) | 2002-06-24 | 2013-11-13 | Tufts University | Biomatériaux à base de soie et leurs procédés d'utilisation |
WO2004001103A2 (fr) | 2002-06-24 | 2003-12-31 | Tufts University | Biomateriaux a base de soie et procedes d'utilisation |
WO2004062697A2 (fr) | 2003-01-07 | 2004-07-29 | Tufts University | Matières de fibroïne de soie et utilisation de celles-ci |
CA2562415C (fr) | 2003-04-10 | 2015-10-27 | Tufts University | Solution aqueuse concentree de fibroine |
WO2005000483A1 (fr) | 2003-06-06 | 2005-01-06 | Tufts University | Procede de formation d'enrobages inorganiques |
US8178656B2 (en) | 2004-06-11 | 2012-05-15 | Trustees Of Tufts College | Silk-based drug delivery system |
US20080280360A1 (en) | 2004-10-12 | 2008-11-13 | Trustees Of Tufts College | Method for Producing Biomaterial Scaffolds |
WO2006076711A2 (fr) | 2005-01-14 | 2006-07-20 | Trustees Of Tufts College | Proteines hybrides fibreuses et leur utilisation dans la formation de matieres composites organiques/anorganiques de pointe |
US9290579B2 (en) | 2005-04-20 | 2016-03-22 | Trustees Of Tufts College | Covalently immobilized protein gradients in three-dimensional porous scaffolds |
ES2374428T3 (es) | 2005-08-02 | 2012-02-16 | Trustees Of Tufts College | Métodos para la deposición progresiva de recubrimientos de fibroína de seda. |
TW200813225A (en) | 2006-03-06 | 2008-03-16 | Univ Louisiana State | Biocompatible scaffolds and adipose-derived stem cells |
WO2008118133A2 (fr) | 2006-09-26 | 2008-10-02 | Trustees Of Tufts College | Microsphères de soie pour l'encapsulation et la libération contrôlée |
WO2008127402A2 (fr) | 2006-11-03 | 2008-10-23 | Trustees Of Tufts College | Capteur de biopolymère et procédé de fabrication de celui-ci |
WO2008118211A2 (fr) | 2006-11-03 | 2008-10-02 | Trustees Of Tufts College | Cristaux photoniques biopolymères et procédés de fabrication de ceux-ci |
WO2008127405A2 (fr) | 2006-11-03 | 2008-10-23 | Trustees Of Tufts College | Dispositif microfluidique avec un microcanal cylindrique et un procédé de fabrication de celui-ci |
US8574461B2 (en) | 2006-11-03 | 2013-11-05 | Tufts University | Electroactive biopolymer optical and electro-optical devices and method of manufacturing the same |
CA2704769C (fr) | 2006-11-03 | 2016-01-12 | Trustees Of Tufts College | Dispositif optique de biopolymere a nanomotifs et procede de fabrication de celui-ci |
US8975073B2 (en) | 2006-11-21 | 2015-03-10 | The Charles Stark Draper Laboratory, Inc. | Microfluidic device comprising silk films coupled to form a microchannel |
WO2008085904A1 (fr) | 2007-01-05 | 2008-07-17 | Charles Stark Draper Laboratory, Inc. | Dispositifs électroniques biodégradables |
EP2112930B1 (fr) * | 2007-02-21 | 2017-01-11 | Vaccinex, Inc. | Modulation d'activité de cellule nkt avec des molécules cdid chargées en antigène |
WO2008106485A2 (fr) | 2007-02-27 | 2008-09-04 | Trustees Of Tufts College | Organes de soie produits par génie tissulaire |
DK2211876T3 (en) | 2007-05-29 | 2015-01-12 | Tufts College | PROCESS FOR silk fibroin-GELATION USING sonication |
JP2011504421A (ja) | 2007-11-05 | 2011-02-10 | トラスティーズ オブ タフツ カレッジ | ナノコンタクトインプリンティングによる絹フィブロインフォトニック構造の作製 |
US20110218143A1 (en) * | 2007-11-20 | 2011-09-08 | University Of Florida Research Foundation | Compositions and methods for tissue repair |
EP2249886A4 (fr) | 2008-02-07 | 2013-05-22 | Tufts College | Compositions d'hydroxyapatite et de soie en trois dimensions |
US8206774B2 (en) | 2008-03-13 | 2012-06-26 | Trustees Of Tufts College | Diazonium salt modification of silk polymer |
US9068282B2 (en) | 2008-04-08 | 2015-06-30 | Trustees Of Tufts College | System and method for making biomaterial structures |
WO2009155397A2 (fr) | 2008-06-18 | 2009-12-23 | Trustees Of Tufts College | Produits holographiques comestibles en soie |
US8976938B2 (en) * | 2008-07-07 | 2015-03-10 | Centurylink Intellectual Property Llc | Deluxe emergency notification |
US8501172B2 (en) | 2008-09-26 | 2013-08-06 | Trustees Of Tufts College | pH-induced silk gels and uses thereof |
KR20110094277A (ko) | 2008-10-09 | 2011-08-23 | 트러스티즈 오브 터프츠 칼리지 | 글리세롤을 함유하는 변성 실크 필름 |
US9427499B2 (en) | 2008-11-17 | 2016-08-30 | Trustees Of Tufts College | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials |
NZ593280A (en) | 2008-12-15 | 2013-01-25 | Allergan Inc | A prosthetic device comprising a knitted mesh including at least two yarns and method of manufacturing the same |
EP2403551A4 (fr) * | 2009-03-04 | 2014-02-26 | Tufts College | Systèmes de fibroïne de soie pour apport antibiotique |
US20110111031A1 (en) | 2009-04-20 | 2011-05-12 | Guang-Liang Jiang | Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
US20110052695A1 (en) | 2009-04-20 | 2011-03-03 | Allergan, Inc. | Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
ES2443045T5 (es) | 2009-04-20 | 2021-05-10 | Allergan Inc | Hidrogeles de fibroína de seda y usos de éstos |
WO2011005381A2 (fr) | 2009-06-01 | 2011-01-13 | Trustees Of Tufts College | Gélification de la fibroïne par traitement au vortex servant dans des applications dencapsulation et dadministration |
EP2451953A4 (fr) | 2009-07-10 | 2013-07-03 | Tufts College | Système d administration d acide nucléique à base de protéine de soie biologiquement modifiée |
US8293486B2 (en) | 2009-07-21 | 2012-10-23 | Trustees Of Tufts College | Functionalization of silk material by avidin-biotin interaction |
WO2011031854A1 (fr) | 2009-09-11 | 2011-03-17 | Allergan, Inc. | Dispositif prothétique et son procédé de fabrication |
CN101891962B (zh) * | 2010-07-22 | 2012-06-06 | 苏州大学 | 丝素蛋白多孔三维材料的制备方法 |
CN103328034A (zh) | 2010-09-03 | 2013-09-25 | 塔夫茨大学/塔夫茨学院信托人 | 掺杂有等离子体纳米颗粒的丝材 |
WO2012145594A2 (fr) | 2011-04-20 | 2012-10-26 | Trustees Of Tufts College | Géométries moulées en soie régénérée avec régulation de température et traitement mécanique |
-
2012
- 2012-12-31 WO PCT/US2012/072275 patent/WO2013102193A1/fr active Application Filing
- 2012-12-31 CA CA2865796A patent/CA2865796A1/fr not_active Abandoned
- 2012-12-31 BR BR112014016154A patent/BR112014016154A8/pt not_active IP Right Cessation
- 2012-12-31 EP EP12862472.3A patent/EP2797641B1/fr active Active
- 2012-12-31 KR KR1020147020822A patent/KR20140108705A/ko not_active Application Discontinuation
- 2012-12-31 US US14/369,658 patent/US20150010630A1/en not_active Abandoned
-
2015
- 2015-03-10 HK HK15102410.1A patent/HK1201761A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR112014016154A8 (pt) | 2017-07-04 |
US20150010630A1 (en) | 2015-01-08 |
KR20140108705A (ko) | 2014-09-12 |
BR112014016154A2 (pt) | 2017-06-13 |
EP2797641A1 (fr) | 2014-11-05 |
WO2013102193A1 (fr) | 2013-07-04 |
EP2797641A4 (fr) | 2015-07-29 |
CA2865796A1 (fr) | 2013-07-04 |
EP2797641B1 (fr) | 2019-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1201761A1 (en) | Functionalization of biomaterials to control regeneration and inflammation responses | |
EP2717931A4 (fr) | Pansements et procédés associés pour ceux-ci | |
IL226401A0 (en) | Methods for treating disorders related to @fgfBA | |
IL269166A (en) | Methods and preparations for treating inflammation | |
SG11201403276TA (en) | Modified microorganisms and methods of making butadiene using same | |
EP2742051A4 (fr) | Forme amorphe de dolutegravir | |
EP2717926A4 (fr) | Compositions et procédés pour prévenir et traiter des biofilms | |
PL2637618T3 (pl) | Produkt chłonny i sposób wytwarzania produktu chłonnego | |
EP2684167A4 (fr) | Compositions et méthodes utiles dans le traitement de maladies | |
EP2747724A4 (fr) | Procédé d'application d'éléments structuraux sur un article absorbant | |
HK1205759A1 (en) | Treatment of biomass | |
HK1199015A1 (en) | Treatment of inflammation | |
HUE039748T2 (hu) | Akuszto-optikai deflektorokat szabályozó módszerek és berendezések | |
SI2682409T1 (sl) | Derivat hialuronske kisline modificiran z amino-karboksilno kislino | |
EP2909374A4 (fr) | Nouveaux adhésifs de crêpage et procédés de contrôle et de commande de leur application | |
ZA201404281B (en) | Methods and products to diagnose and treat heatiness | |
EP2699198A4 (fr) | Dispositifs médicaux biodégradables et procédé pour contrôler la dégradation desdits dispositifs médicaux biodégradables | |
EP2670245A4 (fr) | Alpha-cétohétérocycles et leurs procédés de fabrication et d'utilisation | |
EP2538964A4 (fr) | Modulation des réponses inflammatoires chroniques induites par la cytokine | |
EP2888395A4 (fr) | Procédés et appareil permettant d'assembler des actionneurs | |
ZA201309109B (en) | Methods of treating biomass | |
ZA201307230B (en) | Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma-glutamyl-l-tryptophan | |
GB201103053D0 (en) | Voltage adaption unit and method of use thereof | |
GB201117562D0 (en) | Improving to and relating to toothbrushes | |
IL231452A0 (en) | Amorphous form of dolutegravir |